Thomas R. Spitzer

Hematology
55 Fruit St
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications

Kidney Transplantation in Two Highly Sensitized Candidates after CAR T-Cell Therapy.

Kidney Transplantation in Two Highly Sensitized Candidates after CAR T-Cell Therapy.

Journal: The New England journal of medicine
Published: June 03, 2026

Reduced-Dose Post-Transplant Cyclophosphamide (PTCy 40-40) in Allogeneic Hematopoietic Cell Transplantation.

Reduced-Dose Post-Transplant Cyclophosphamide (PTCy 40-40) in Allogeneic Hematopoietic Cell Transplantation.

Journal: Transplantation and cellular therapy
Published: May 26, 2026

Incidence of and Risk Factors for Delayed Engraftment after Post-Transplant Cyclophosphamide.

Incidence of and Risk Factors for Delayed Engraftment after Post-Transplant Cyclophosphamide.

Journal: Transplantation and cellular therapy
Published: December 15, 2025

Training in cell and gene therapy manufacturing: Unmet needs and arguments for graduate medical education.

Training in cell and gene therapy manufacturing: Unmet needs and arguments for graduate medical education.

Journal: Transfusion
Published: August 11, 2025

Cytokines in hematology, hematopoietic cell transplantation and immune effector cell therapy: Preface.

Cytokines in hematology, hematopoietic cell transplantation and immune effector cell therapy: Preface.

Journal: Best practice & research. Clinical haematology
Published: July 23, 2025

Safe and Effective Addition of Ruxolitinib to Graft-versus-host Prophylaxis in Older Adults Undergoing Reduced-intensity Allogeneic Hematopoietic Cell Transplantation.

Safe and Effective Addition of Ruxolitinib to Graft-versus-host Prophylaxis in Older Adults Undergoing Reduced-intensity Allogeneic Hematopoietic Cell Transplantation.

Journal: Transplantation and cellular therapy
Published: July 08, 2025

Chimerism and a framework for clinical practice: A report from the Cellular Therapies Section Coordinating Committee (CTSCC) of Association for Advancement of Blood and Biotherapies (AABB).

Chimerism and a framework for clinical practice: A report from the Cellular Therapies Section Coordinating Committee (CTSCC) of Association for Advancement of Blood and Biotherapies (AABB).

Journal: Transfusion
Published: June 24, 2025

A Web-Based Calculator for Hematopoietic Progenitor Cell Collections: App Development and Retrospective Assessment.

A Web-Based Calculator for Hematopoietic Progenitor Cell Collections: App Development and Retrospective Assessment.

Journal: Journal of clinical apheresis
Published: May 28, 2025

Cytokines in transplantation tolerance.

Cytokines in transplantation tolerance.

Journal: Best practice & research. Clinical haematology
Published: April 05, 2025

Endogenous and exogenous cytokines: An overview and introduction.

Endogenous and exogenous cytokines: An overview and introduction.

Journal: Best practice & research. Clinical haematology
Published: February 06, 2025

Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT.

Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT.

Journal: Blood
Published: December 20, 2024

A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation.

A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation.

Journal: Leukemia research
Published: November 07, 2024
Showing 1-12 of 103

Last Updated: 09/26/2026